FDA Issues Drug Recall, Urges Patients to Check Medications
June 26, 2026
The U.S. Food and Drug Administration is urging patients to review their prescriptions after a nationwide recall of more than 11,000 bottles of chlorthalidone, a medication commonly used to treat high blood pressure. The recall was issued after the drug failed dissolution testing, meaning it may not work as intended once taken.
The FDA classified the action as a Class II recall, signaling the potential for temporary or medically reversible health effects. Patients are advised to check lot numbers and consult their pharmacist or health care provider before stopping the medication.



